We found that FAM99A was remarkably downregulated in 98.39% (61/62) of HCC samples (1.84 ± 3.62 vs. 22.27 ± 14.27; P < 0.001; Fig. 3A, B). Here, FAM99A is linked to hepatocellular carcinoma.